Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis
Background Pharmaceutical companies make hundreds of millions of pounds in marketing/R&D-related
payments annually to healthcare organisations and healthcare professionals. …
payments annually to healthcare organisations and healthcare professionals. …
Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series
…, H Ansari, I Syed, K Balaraj, F Azribi… - Case Reports in …, 2023 - karger.com
Novel coronavirus-19 (COVID-19) variants continue to spread worldwide with the development
of highly transmissible strains. Several guidelines addressing management of cancer …
of highly transmissible strains. Several guidelines addressing management of cancer …
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
…, H Jaafar, SH Tirmazy, M Elkhoury, F Azribi… - The Gulf journal of …, 2020 - europepmc.org
With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there
has been significant investment from the government and private health care providers to …
has been significant investment from the government and private health care providers to …
Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study
Background Patients with pathogenic sequence variants (PSVs) in BRCA1/BRCA2 are at
high risk of developing ovarian cancer (OC). However, genetic testing for BRCA1/BRCA2 …
high risk of developing ovarian cancer (OC). However, genetic testing for BRCA1/BRCA2 …
Abstract P1-14-01: Incidence, Clinicopathological Features and Treatment Outcomes Of Young Breast Cancer Patients: A Cohort Analysis From a High-Volume …
…, A Yousif, M AlShebli, D Trad, A Masih, F Azribi… - Cancer Research, 2023 - AACR
Introduction: Breast cancer (BC) in women age 40 or younger represents approximately 7%
of all BC cases. Studies have reported that BC in younger women is more likely to have …
of all BC cases. Studies have reported that BC in younger women is more likely to have …
Abstract P5-03-04: PIK3CA mutation prevalence in hormone receptor positive breast cancer patients in United Arab Emirates
F Azribi, M Hourani, S Magdub, A Alawadhi, A Yousif… - Cancer Research, 2023 - AACR
Background: The Phosphatidylinositol-4,5-bisphosphonate 3-kinase catalytic subunit alpha (PIK3CA)
gene is mutated in about 30-40% of hormone receptor positive/human epidermal …
gene is mutated in about 30-40% of hormone receptor positive/human epidermal …
[PDF][PDF] Model predictive control
YG Xi - National Defense Industry Press, Beijing, 1993 - downloads.hindawi.com
This paper addresses a distributed model predictive control (DMPC) scheme for multiagent
systems with improving control performance. In order to penalize the deviation of the …
systems with improving control performance. In order to penalize the deviation of the …
143P Prevalence of BRCA1/2 mutations in patients with ovarian cancer in the Gulf region: The PREDICT study
Background Patients with germline mutations in BRCA1/2 are at high risk of developing
ovarian cancer (OC). However, genetic testing for BRCA1/2 mutations is still not a routine …
ovarian cancer (OC). However, genetic testing for BRCA1/2 mutations is still not a routine …
[HTML][HTML] Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast …
…, RL López, O Del Val, O Ozyilkan, F Azribi… - Annals of …, 2019 - Elsevier
Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line
therapy for HER2-positive metastatic breast cancer, based on results from the phase III …
therapy for HER2-positive metastatic breast cancer, based on results from the phase III …
Oncocytic Carcinoma with Liver Metastasis: Unusual Treatment Strategies and Clinical Insights—A Case Report and Review of the Literature
M Hourani, S Giridharan, F Azribi… - Case Reports in …, 2024 - Wiley Online Library
We report a distinctive case of malignant oncocytic carcinoma originating in the pancreas, an
organ rarely associated with such tumours. We discuss the diagnostic journey, highlighting …
organ rarely associated with such tumours. We discuss the diagnostic journey, highlighting …
